文献速递药物不良反应与药物警戒药物相互作用

QTc药物相互作用临床决策支持警报的评估与Tisdale风险评分计算器的表现

A Calculated Risk: Evaluation of QTc Drug-Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator.
PubMed 文献 · Drug Saf · 2024-07-09

该研究回顾性分析了2022年Brigham and Women's Hospital成人住院患者中QTc DDI CDS警报的覆盖情况,共2649例患者3033次入院产生18432条被覆盖的警报。结果显示29%的入院发生药物诱导的QTc延长,且高风险Tisdale评分患者中diQTP更频繁。结论提示结合Tisdale计算器与CDS可能提高警报质量和接受率,从而降低diQTP率。

要点

  • 每例入院平均呈现3条独特QTc DDI警报,平均被覆盖6次。
  • diQTP发生在29%的入院中,高风险评分患者占46%。
  • 最常见导致diQTP的覆盖警报为喹硫平+丙泊酚(11%)和胺碘酮+氟哌啶醇(7%)。

核心结论

  • 使用Tisdale计算器评估患者特异性QT延长风险并结合CDS可能提高警报质量和接受率,从而可能降低diQTP率。

研究设计与样本

  • 回顾性研究,使用机构企业数据仓库访问2022年Brigham and Women's Hospital年龄≥18岁住院患者的QTc DDI警报,纳入住院期间至少2天且警报展示给医生、研究员、住院医师、医师助理或执业护士的警报。

主要发现

  • 共2649例患者3033次入院产生18432条被覆盖的QTc DDI警报,平均每例入院3条独特警报,平均被覆盖6次。
  • 6%的入院为低风险(评分≤6),64%为中风险(评分7-10),30%为高风险(评分≥11)。
  • diQTP发生在883例入院(29%),高风险评分患者中46%发生diQTP,中风险23%,低风险8%。
  • 最常见导致diQTP的覆盖警报为喹硫平与丙泊酚(11%)和胺碘酮与氟哌啶醇(7%)。

关键数值与推荐

  • Tisdale风险评分分类:低风险≤6分,中风险7-10分,高风险≥11分。
  • QTc延长定义:心率校正QT间期≥500毫秒或较基线增加≥60毫秒。

临床怎么用

  • 临床可考虑使用Tisdale风险评分计算器评估住院患者QTc延长风险,并结合CDS优化警报管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A risk factor for a potentially fatal ventricular arrhythmia Torsade de Pointes is a prolongation in the heart rate-corrected QT interval (QTc) ≥ 500 milliseconds (ms) or an increase of ≥ 60 ms from a patient's baseline value, which can cause sudden cardiac death. The Tisdale risk score calculator uses clinical variables to predict which hospitalized patients are at the highest risk for QTc prolongation. OBJECTIVE: To determine the rate of overridden QTc drug-drug interaction (DDI)-related clinical decision support (CDS) alerts per patient admission and the prevalence by Tisdale risk score category of these overridden alerts. Secondary outcome was to determine the rate of drug-induced QTc prolongation (diQTP) associated with overrides. METHODS: Our organization's enterprise data warehouse was used to retrospectively access QTc DDI alerts presented for patients aged ≥ 18 years who were admitted to Brigham and Women's Hospital during 2022. The QTc DDI CDS alerts were included if shown to a physician, fellow, resident, physician assistant, or nurse practitioner when entering the order in inpatient areas for patients with a length of stay of at least 2 days. Variables collected for the Tisdale calculator included age, sex, whether patient was on a loop diuretic, potassium level, admission QTc value, admitting diagnosis of acute myocardial infarction, sepsis, or heart failure, and number of QTc-prolonging drugs given to the patient. RESULTS: A total of 2649 patients with 3033 patient admissions had 18,432 QTc DDI alerts presented that were overridden. An average of 3 unique QTc DDI alerts were presented per patient admission and the alerts were overridden an average of 6 times per patient admission. Overall, 6% of patient admissions were low risk (score ≤ 6), 64% moderate risk (score 7-10), and 30% high risk (score ≥ 11) of QTc prolongation. The most common QTc DDI alerts overridden resulting in an diQTP were quetiapine and propofol (11%) and amiodarone and haloperidol (7%). The diQTP occurred in 883 of patient admissions (29%) and was more frequent in those with higher risk score, with 46% of patient admissions with diQTP in high risk, 23% in moderate risk, and 8% in low risk. CONCLUSION: Use of the Tisdale calculator to assess patient-specific risk of QT prolongation combined with CDS may improve overall alert quality and acceptance rate, which may decrease the diQTP rate.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Wasserman RL, Seger DL, Amato MG, et al. A Calculated Risk: Evaluation of QTc Drug-Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator. Drug Saf. 2024. PMID: 38982033. doi:10.1007/s40264-024-01466-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。